Lipid and Protein Oxidation in Newborn Infants after Lutein Administration

Table 1

Clinical characteristics of patients.

Clinical characteristic	Control group	Test group
Number of patients*	47 (100)	103 (100)
Sex*
Male	22 (47)	57 (55)
Female	25 (53)	46 (45)
Gestational Age^# (weeks)	38.18 ± 1.23	38.58 ± 1.33
Weight^# (grams)	2964.37 ± 292.16	3237.73 ± 416.89
APGAR 1° minute^#	9.44 ± 0.89	9.25 ± 1.11
APGAR 5° minute^#	9.75 ± 0.58	9.78 ± 0.69
Type of delivery*
Vaginal	12 (26)	37 (36)
Elective caesarean section	32 (68)	61 (59)
Emergency caesarean section	3 (6)	3 (5)
Premature rupture of membranes*
<18 h	44 (94)	95 (92)
>18 h	3 (6)	8 (8)
Amniotic fluid*
Clear	45 (96)	98 (95)
Stained	2 (4)	5 (5)
Vaginal swab*
Negative	27 (57)	52 (51)
Remote or not performed	12 (26)	29 (28)
Positive	8 (17)	22 (21)
Maternal intrapartum prophylaxis*
Not performed	32 (68)	80 (78)
Incomplete	9 (19)	12 (11)
Complete	6 (13)	11 (11)
C-reactive Protein^# (mg/dL)
24 hours of life	0.2 ± 0.09	0.21 ± 0.26
48 hours of life	0.26 ± 0.13	0.3 ± 0.41

#mean ± SD; ^∗𝑛 (%).